======= TGFB3 ======= == Gene Information == * **Official Symbol**: TGFB3 * **Official Name**: transforming growth factor beta 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7043|7043]] * **UniProt**: [[https://www.uniprot.org/uniprot/P10600|P10600]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TGFB3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TGFB3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/190230|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. This protein is involved in embryogenesis and cell differentiation, and may play a role in wound healing. Mutations in this gene are a cause of aortic aneurysms and dissections, as well as familial arrhythmogenic right ventricular dysplasia 1. [provided by RefSeq, Aug 2016]. * **UniProt Summary**: Involved in embryogenesis and cell differentiation. |TGFb propeptide| |TGF beta| |detection of hypoxia| |detection of oxygen| |regulation of tight junction disassembly| |uterine wall breakdown| |positive regulation of tight junction disassembly| |type III transforming growth factor beta receptor binding| |frontal suture morphogenesis| |ossification involved in bone remodeling| |negative regulation of macrophage cytokine production| |embryonic neurocranium morphogenesis| |type II transforming growth factor beta receptor binding| |regulation of epithelial to mesenchymal transition involved in endocardial cushion formation| |cranial suture morphogenesis| |type I transforming growth factor beta receptor binding| |regulation of cardiac epithelial to mesenchymal transition| |positive regulation of SMAD protein signal transduction| |response to laminar fluid shear stress| |regulation of macrophage cytokine production| |negative regulation of vascular smooth muscle cell proliferation| |craniofacial suture morphogenesis| |transforming growth factor beta binding| |regulation of SMAD protein signal transduction| |secondary palate development| |negative regulation of cytokine production involved in immune response| |positive regulation of collagen biosynthetic process| |positive regulation of collagen metabolic process| |salivary gland morphogenesis| |positive regulation of filopodium assembly| |salivary gland development| |face morphogenesis| |response to fluid shear stress| |negative regulation of production of molecular mediator of immune response| |regulation of collagen biosynthetic process| |head morphogenesis| |positive regulation of bone mineralization| |regulation of heart morphogenesis| |regulation of collagen metabolic process| |lung alveolus development| |transforming growth factor beta receptor binding| |ovulation cycle process| |T-tubule| |exocrine system development| |negative regulation of smooth muscle cell proliferation| |regulation of filopodium assembly| |embryonic cranial skeleton morphogenesis| |response to progesterone| |body morphogenesis| |bone remodeling| |positive regulation of biomineral tissue development| |positive regulation of biomineralization| |positive regulation of epithelial to mesenchymal transition| |positive regulation of pathway-restricted SMAD protein phosphorylation| |face development| |regulation of vascular smooth muscle cell proliferation| |positive regulation of stress fiber assembly| |SMAD protein signal transduction| |regulation of pathway-restricted SMAD protein phosphorylation| |positive regulation of actin filament bundle assembly| |cranial skeletal system development| |ovulation cycle| |platelet alpha granule lumen| |negative regulation of transforming growth factor beta receptor signaling pathway| |regulation of bone mineralization| |negative regulation of cellular response to transforming growth factor beta stimulus| |response to estrogen| |regulation of stress fiber assembly| |regulation of epithelial to mesenchymal transition| |regulation of cytokine production involved in immune response| |positive regulation of ossification| |positive regulation of cell division| |regulation of actomyosin structure organization| |roof of mouth development| |regulation of actin filament bundle assembly| |regulation of biomineral tissue development| |regulation of biomineralization| |embryonic skeletal system morphogenesis| |gland morphogenesis| |tissue remodeling| |positive regulation of plasma membrane bounded cell projection assembly| |transforming growth factor beta receptor signaling pathway| |positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of transforming growth factor beta receptor signaling pathway| |bone morphogenesis| |regulation of cellular response to transforming growth factor beta stimulus| |negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |odontogenesis| |negative regulation of immune effector process| |embryonic skeletal system development| |mammary gland development| |platelet degranulation| |digestive tract development| |regulation of smooth muscle cell proliferation| |cell-cell junction organization| |regulation of production of molecular mediator of immune response| |digestive system development| |negative regulation of neuron apoptotic process| |negative regulation of cellular response to growth factor stimulus| |negative regulation of immune response| |activation of MAPK activity| |cellular response to transforming growth factor beta stimulus| |response to transforming growth factor beta| |growth factor activity| |regulation of cell division| |lung development| |respiratory tube development| |cytokine activity| |female pregnancy| |regulation of ossification| |inner ear development| |response to ketone| |respiratory system development| |positive regulation of supramolecular fiber organization| |transmembrane receptor protein serine/threonine kinase signaling pathway| |bone development| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |regulation of neuron apoptotic process| |negative regulation of neuron death| |multi-multicellular organism process| |cell junction organization| |positive regulation of cytoskeleton organization| |ear development| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |skeletal system morphogenesis| |regulation of animal organ morphogenesis| |regulation of actin filament organization| |positive regulation of MAP kinase activity| |ossification| |positive regulation of protein secretion| |regulation of cellular response to growth factor stimulus| |negative regulation of cytokine production| |rhythmic process| |aging| |embryonic organ morphogenesis| |positive regulation of peptide secretion| |regulation of neuron death| |response to steroid hormone| |activation of protein kinase activity| |positive regulation of protein serine/threonine kinase activity| |regulation of MAP kinase activity| |response to hypoxia| |regulation of actin cytoskeleton organization| |regulation of supramolecular fiber organization| |response to decreased oxygen levels| |collagen-containing extracellular matrix| |neuronal cell body| |in utero embryonic development| |response to oxygen levels| |positive regulation of cell projection organization| |regulation of actin filament-based process| |positive regulation of secretion by cell| |gland development| |positive regulation of protein transport| |embryonic organ development| |positive regulation of secretion| |negative regulation of immune system process| |positive regulation of establishment of protein localization| |regulation of protein secretion| |regulation of immune effector process| |wound healing| |protein heterodimerization activity| |skeletal system development| |regulation of peptide secretion| |cellular response to growth factor stimulus| |regulation of protein serine/threonine kinase activity| |positive regulation of cellular component biogenesis| |detection of chemical stimulus| |response to growth factor| |positive regulation of protein kinase activity| |regulation of cytoskeleton organization| |positive regulation of MAPK cascade| |sensory organ development| |embryonic morphogenesis| |response to wounding| |positive regulation of kinase activity| |cell surface| |positive regulation of organelle organization| |chordate embryonic development| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |embryo development ending in birth or egg hatching| |positive regulation of transferase activity| |negative regulation of cell population proliferation| |intracellular membrane-bounded organelle| |detection of stimulus| |regulation of plasma membrane bounded cell projection organization| |regulation of cytokine production| |positive regulation of cell death| |regulated exocytosis| |regulation of protein transport| |regulation of cell projection organization| |enzyme linked receptor protein signaling pathway| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of MAPK cascade| |head development| |exocytosis| |regulation of protein kinase activity| |regulation of secretion| |multicellular organismal reproductive process| |multicellular organism reproduction| |tube development| |response to lipid| |regulation of kinase activity| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |response to hormone| |positive regulation of cell population proliferation| |response to organic cyclic compound| |animal organ morphogenesis| |regulation of cellular component biogenesis| |positive regulation of cell differentiation| |embryo development| |regulation of transferase activity| |positive regulation of transport| |negative regulation of cell death| |multi-organism reproductive process| |secretion by cell| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |response to drug| |regulation of protein localization| |export from cell| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |identical protein binding| |secretion| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |regulation of immune response| |response to abiotic stimulus| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |negative regulation of signal transduction| |regulation of organelle organization| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |reproductive process| |reproduction| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |regulation of immune system process| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |extracellular region| |vesicle-mediated transport| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp11|CCCP 1μM R00 exp11]]|-1.9| |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|-1.72| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11174 * **Expression level (log2 read counts)**: 1.08 {{:chemogenomics:nalm6 dist.png?nolink |}}